Johnson & Johnson (JNJ) Operating Expenses (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Operating Expenses data on file, last reported at $9.6 billion in Q1 2026.

• Quarterly Operating Expenses rose 14.83% year-over-year to $9.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 billion (down 36.43% YoY) and the FY2025 annual result came in at $24.0 billion, down 40.47% from the prior year.
• Operating Expenses advanced to $9.6 billion in Q1 2026 per JNJ's latest filing, from -$3.5 billion in the prior quarter.
• The five-year high for Operating Expenses was $11.8 billion in Q4 2024, with the low at -$10.6 billion in Q1 2022.
• Average Operating Expenses over 5 years is $6.6 billion, with a median of $9.1 billion recorded in 2023.
• Year-over-year, Operating Expenses sank 261.96% in 2022 and jumped 377.09% in 2024.
• Johnson & Johnson's Operating Expenses stood at $8.5 billion in 2022, then sank by 149.92% to -$4.3 billion in 2023, then surged by 377.09% to $11.8 billion in 2024, then slumped by 129.4% to -$3.5 billion in 2025, then surged by 376.69% to $9.6 billion in 2026.
• Business Quant data shows JNJ's Operating Expenses at $9.6 billion in Q1 2026, -$3.5 billion in Q4 2025, and $9.7 billion in Q3 2025.